The role of human achaete-scute homolog-1 in medullary thyroid cancer cells

Rebecca S. Sippel, Jennifer E. Carpenter, Muthusamy Kunnimalaiyaan, Herbert Chen, Fiemu Nwariaku, Tobias Carling, John E. Olson, Martha A. Zeiger

Research output: Contribution to journalArticle

Abstract

Background. Human achaete-scute homolog-1 (hASH1) is a transcription factor that is expressed highly in neuroendocrine tumors such as medullary thyroid cancer (MTC). Thyroid C-cells do not develop in hASH1 knockout mice, which suggests that hASH1 is essential for normal C-cell development. Methods. To determine the effect of raf-1 induction on hASH1 and hormone production, we used an estrogen inducible raf-1 construct in MTC cell line (TT) cells (TT-raf cells). TT or TT-raf cells were treated with control or 1 μM estradiol. After 48 hours, the cells were analyzed for levels of hASH1 and chromogranin A by Western blotting and for calcitonin production by enzyme-linked immunosorbent assay. Results. Activation of raf-1 in the TT-raf cells resulted in high levels of phosphorylated MEK and ERK1/2, a morphologic transdifferentiation, and a decrease in chromogranin A and calcitonin levels that are associated with a reduction in hASH1 production. Furthermore, using MEK inhibitors, we demonstrated that these raf-1-mediated changes are dependent on MEK but not ERK1/2 activation. Conclusion. hASH1 down-regulation by raf-1 in MTC cells is associated with a significant decrease in hormone production. Thus, hASH1 appears to be important in the endocrine phenotype of MTC tumors and may serve as a molecular target for the treatment of patients with MTC.

Original languageEnglish (US)
Pages (from-to)866-873
Number of pages8
JournalSurgery
Volume134
Issue number6
DOIs
StatePublished - Dec 2003
Externally publishedYes

Fingerprint

Mitogen-Activated Protein Kinase Kinases
Chromogranin A
Calcitonin
Hormones
Neuroendocrine Tumors
Medullary Thyroid cancer
Knockout Mice
Estradiol
Thyroid Gland
Estrogens
Transcription Factors
Down-Regulation
Western Blotting
Enzyme-Linked Immunosorbent Assay
Phenotype
Cell Line
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Surgery

Cite this

Sippel, R. S., Carpenter, J. E., Kunnimalaiyaan, M., Chen, H., Nwariaku, F., Carling, T., ... Zeiger, M. A. (2003). The role of human achaete-scute homolog-1 in medullary thyroid cancer cells. Surgery, 134(6), 866-873. https://doi.org/10.1016/S0039-6060(03)00418-5

The role of human achaete-scute homolog-1 in medullary thyroid cancer cells. / Sippel, Rebecca S.; Carpenter, Jennifer E.; Kunnimalaiyaan, Muthusamy; Chen, Herbert; Nwariaku, Fiemu; Carling, Tobias; Olson, John E.; Zeiger, Martha A.

In: Surgery, Vol. 134, No. 6, 12.2003, p. 866-873.

Research output: Contribution to journalArticle

Sippel, RS, Carpenter, JE, Kunnimalaiyaan, M, Chen, H, Nwariaku, F, Carling, T, Olson, JE & Zeiger, MA 2003, 'The role of human achaete-scute homolog-1 in medullary thyroid cancer cells', Surgery, vol. 134, no. 6, pp. 866-873. https://doi.org/10.1016/S0039-6060(03)00418-5
Sippel RS, Carpenter JE, Kunnimalaiyaan M, Chen H, Nwariaku F, Carling T et al. The role of human achaete-scute homolog-1 in medullary thyroid cancer cells. Surgery. 2003 Dec;134(6):866-873. https://doi.org/10.1016/S0039-6060(03)00418-5
Sippel, Rebecca S. ; Carpenter, Jennifer E. ; Kunnimalaiyaan, Muthusamy ; Chen, Herbert ; Nwariaku, Fiemu ; Carling, Tobias ; Olson, John E. ; Zeiger, Martha A. / The role of human achaete-scute homolog-1 in medullary thyroid cancer cells. In: Surgery. 2003 ; Vol. 134, No. 6. pp. 866-873.
@article{c03f1f98c9d847a1a5eea84815b3c017,
title = "The role of human achaete-scute homolog-1 in medullary thyroid cancer cells",
abstract = "Background. Human achaete-scute homolog-1 (hASH1) is a transcription factor that is expressed highly in neuroendocrine tumors such as medullary thyroid cancer (MTC). Thyroid C-cells do not develop in hASH1 knockout mice, which suggests that hASH1 is essential for normal C-cell development. Methods. To determine the effect of raf-1 induction on hASH1 and hormone production, we used an estrogen inducible raf-1 construct in MTC cell line (TT) cells (TT-raf cells). TT or TT-raf cells were treated with control or 1 μM estradiol. After 48 hours, the cells were analyzed for levels of hASH1 and chromogranin A by Western blotting and for calcitonin production by enzyme-linked immunosorbent assay. Results. Activation of raf-1 in the TT-raf cells resulted in high levels of phosphorylated MEK and ERK1/2, a morphologic transdifferentiation, and a decrease in chromogranin A and calcitonin levels that are associated with a reduction in hASH1 production. Furthermore, using MEK inhibitors, we demonstrated that these raf-1-mediated changes are dependent on MEK but not ERK1/2 activation. Conclusion. hASH1 down-regulation by raf-1 in MTC cells is associated with a significant decrease in hormone production. Thus, hASH1 appears to be important in the endocrine phenotype of MTC tumors and may serve as a molecular target for the treatment of patients with MTC.",
author = "Sippel, {Rebecca S.} and Carpenter, {Jennifer E.} and Muthusamy Kunnimalaiyaan and Herbert Chen and Fiemu Nwariaku and Tobias Carling and Olson, {John E.} and Zeiger, {Martha A.}",
year = "2003",
month = "12",
doi = "10.1016/S0039-6060(03)00418-5",
language = "English (US)",
volume = "134",
pages = "866--873",
journal = "Surgery",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - The role of human achaete-scute homolog-1 in medullary thyroid cancer cells

AU - Sippel, Rebecca S.

AU - Carpenter, Jennifer E.

AU - Kunnimalaiyaan, Muthusamy

AU - Chen, Herbert

AU - Nwariaku, Fiemu

AU - Carling, Tobias

AU - Olson, John E.

AU - Zeiger, Martha A.

PY - 2003/12

Y1 - 2003/12

N2 - Background. Human achaete-scute homolog-1 (hASH1) is a transcription factor that is expressed highly in neuroendocrine tumors such as medullary thyroid cancer (MTC). Thyroid C-cells do not develop in hASH1 knockout mice, which suggests that hASH1 is essential for normal C-cell development. Methods. To determine the effect of raf-1 induction on hASH1 and hormone production, we used an estrogen inducible raf-1 construct in MTC cell line (TT) cells (TT-raf cells). TT or TT-raf cells were treated with control or 1 μM estradiol. After 48 hours, the cells were analyzed for levels of hASH1 and chromogranin A by Western blotting and for calcitonin production by enzyme-linked immunosorbent assay. Results. Activation of raf-1 in the TT-raf cells resulted in high levels of phosphorylated MEK and ERK1/2, a morphologic transdifferentiation, and a decrease in chromogranin A and calcitonin levels that are associated with a reduction in hASH1 production. Furthermore, using MEK inhibitors, we demonstrated that these raf-1-mediated changes are dependent on MEK but not ERK1/2 activation. Conclusion. hASH1 down-regulation by raf-1 in MTC cells is associated with a significant decrease in hormone production. Thus, hASH1 appears to be important in the endocrine phenotype of MTC tumors and may serve as a molecular target for the treatment of patients with MTC.

AB - Background. Human achaete-scute homolog-1 (hASH1) is a transcription factor that is expressed highly in neuroendocrine tumors such as medullary thyroid cancer (MTC). Thyroid C-cells do not develop in hASH1 knockout mice, which suggests that hASH1 is essential for normal C-cell development. Methods. To determine the effect of raf-1 induction on hASH1 and hormone production, we used an estrogen inducible raf-1 construct in MTC cell line (TT) cells (TT-raf cells). TT or TT-raf cells were treated with control or 1 μM estradiol. After 48 hours, the cells were analyzed for levels of hASH1 and chromogranin A by Western blotting and for calcitonin production by enzyme-linked immunosorbent assay. Results. Activation of raf-1 in the TT-raf cells resulted in high levels of phosphorylated MEK and ERK1/2, a morphologic transdifferentiation, and a decrease in chromogranin A and calcitonin levels that are associated with a reduction in hASH1 production. Furthermore, using MEK inhibitors, we demonstrated that these raf-1-mediated changes are dependent on MEK but not ERK1/2 activation. Conclusion. hASH1 down-regulation by raf-1 in MTC cells is associated with a significant decrease in hormone production. Thus, hASH1 appears to be important in the endocrine phenotype of MTC tumors and may serve as a molecular target for the treatment of patients with MTC.

UR - http://www.scopus.com/inward/record.url?scp=0346887056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346887056&partnerID=8YFLogxK

U2 - 10.1016/S0039-6060(03)00418-5

DO - 10.1016/S0039-6060(03)00418-5

M3 - Article

C2 - 14668716

AN - SCOPUS:0346887056

VL - 134

SP - 866

EP - 873

JO - Surgery

JF - Surgery

SN - 0039-6060

IS - 6

ER -